94 related articles for article (PubMed ID: 22207979)
1. [PSA standardization; the past progress and some problems in the future].
Kano S
Nihon Rinsho; 2011 Jun; 69 Suppl 5():238-49. PubMed ID: 22207979
[No Abstract] [Full Text] [Related]
2. [Progress in standardization of total PSA immunoassays].
Ishibashi M
Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
[TBL] [Abstract][Full Text] [Related]
3. [The present status and future directions for standardization of PSA assays in PSA gray zone].
Kurokawa K; Yamanaka H; Ishibashi M; Kano S; Arai Y
Nihon Rinsho; 2002 Dec; 60 Suppl 11():117-22. PubMed ID: 12599556
[No Abstract] [Full Text] [Related]
4. [The present status of standardization in serum total PSA measurement--a result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association].
Kano S; Ishibashi M; Itoh Y;
Rinsho Byori; 2001 Oct; 49(10):967-73. PubMed ID: 11769473
[TBL] [Abstract][Full Text] [Related]
5. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
Kuruma H; Egawa S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
[TBL] [Abstract][Full Text] [Related]
6. Missing agreement between the two IMMULITE® PSA assays.
Fischer K; Theil G; Hoda R; Fornara P
Clin Chem Lab Med; 2013 Apr; 51(4):e37-9. PubMed ID: 23241597
[No Abstract] [Full Text] [Related]
7. Comparison of various assay systems for prostate-specific antigen standardization.
Kuriyama M; Akimoto S; Akaza H; Arai Y; Usami M; Imai K; Tanaka Y; Yamazaki H; Kawada Y; Koiso K
Jpn J Clin Oncol; 1992 Dec; 22(6):393-9. PubMed ID: 1283993
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
[TBL] [Abstract][Full Text] [Related]
9. [Clinical utility of the free prostate specific antigen (PSA), alpha 1-antichymotrypsin-complexed PSA, and free/total PSA ratio using the specific and sensitive enzyme-linked immunosorbent assay "E-plate EIKEN PSA"].
Imai K; Yamanaka H; Kubota Y; Miki M; Ito T; Akaza H; Uchida K; Egawa S; Kuriyama M; Watanabe H; Okihara K; Kotake T; Usami M; Arai Y; Maeda H; Sagiyama K; Saito Y; Sakai H; Shida K
Hinyokika Kiyo; 1998 Oct; 44(10):755-63. PubMed ID: 9850846
[TBL] [Abstract][Full Text] [Related]
10. Issues on standardization of immunoassays for prostate-specific antigen: a review.
Graves HC
Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
[TBL] [Abstract][Full Text] [Related]
11. [Present status of serum total PSA assay and factors responsible for the inter-kit deviations].
Kano S
Nihon Rinsho; 2000 Jul; 58 Suppl():112-7. PubMed ID: 11022696
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of tandem PSA for the diagnosis and follow-up of prostate cancer].
Okaneya T; Mizusawa H; Taguchi I; Yoneyama T
Hinyokika Kiyo; 1996 Nov; 42(11):861-7. PubMed ID: 8973936
[TBL] [Abstract][Full Text] [Related]
13. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
Gray MA; Cooke RR; Weinstein P; Nacey JN
Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
[TBL] [Abstract][Full Text] [Related]
14. [The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method].
Arai K; Honda M; Hosoya Y; Sumi S; Umeda H; Yoshida K
Rinsho Byori; 1996 Apr; 44(4):345-50. PubMed ID: 8847816
[TBL] [Abstract][Full Text] [Related]
15. [Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level].
Tanaka M; Murakami S; Igarashi T; Abe T; Suzuki K; Sekita N; Shimazaki J
Hinyokika Kiyo; 1997 Dec; 43(12):855-60. PubMed ID: 9488932
[TBL] [Abstract][Full Text] [Related]
16. PSA home tests: ban in France is welcome.
Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171220
[TBL] [Abstract][Full Text] [Related]
17. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of TANDEM PSA in Japanese cases and comparison with other methods].
Kuriyama M; Yamamoto N; Shinoda I; Kawada Y; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1995 Jan; 41(1):39-46. PubMed ID: 7534972
[TBL] [Abstract][Full Text] [Related]
19. Role of free PSA in discordance across commercial PSA assays.
Strobel S; Smith K; Wolfert R; Rittenbouse H
Clin Chem; 1996 Apr; 42(4):645-7. PubMed ID: 8605688
[No Abstract] [Full Text] [Related]
20. [Correct use of prostate-specific antigen in office practice].
Desfemmes FR; Deligne E; Ghoundale O; Labarthe P; Berlizot P; Houlgatte A
Prog Urol; 2008 Jan; 18(1):41-5. PubMed ID: 18342155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
